Literature DB >> 23369966

Flushing out antibodies to make AAV gene therapy available to more patients.

Steven E Raper1, James M Wilson, Frederick A Nunes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23369966      PMCID： PMC3596520          DOI： 10.1038/mt.2013.5

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

Review 1.  The hemophilias--from royal genes to gene therapy.

Authors:  P M Mannucci; E G Tuddenham
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

2.  Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity.

Authors:  Anthony N Kalloo; Vikesh K Singh; Sanjay B Jagannath; Hideaki Niiyama; Susan L Hill; Cheryl A Vaughn; Carolyn A Magee; Sergey V Kantsevoy
Journal:  Gastrointest Endosc       Date:  2004-07       Impact factor: 9.427

Review 3.  Isolated hepatic perfusion for the treatment of liver metastases.

Authors:  Brian A Boone; David L Bartlett; Amer H Zureikat
Journal:  Curr Probl Cancer       Date:  2012 Mar-Apr       Impact factor: 3.187

4.  Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

Authors:  H R Alexander; D L Bartlett; S K Libutti; D L Fraker; T Moser; S A Rosenberg
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

5.  Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors.

Authors:  Jun Mimuro; Hiroaki Mizukami; Shuji Hishikawa; Tomokazu Ikemoto; Akira Ishiwata; Asuka Sakata; Tsukasa Ohmori; Seiji Madoiwa; Fumiko Ono; Keiya Ozawa; Yoichi Sakata
Journal:  Mol Ther       Date:  2012-12-18       Impact factor: 11.454

Review 6.  Conceptual review of the hepatic vascular bed.

Authors:  W W Lautt; C V Greenway
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

Review 7.  Use of tumor necrosis factor in isolated hepatic perfusion.

Authors:  D L Fraker; H R Alexander; A K Thom
Journal:  Circ Shock       Date:  1994-09

Review 8.  The gene therapy journey for hemophilia: are we there yet?

Authors:  Katherine A High
Journal:  Blood       Date:  2012-07-24       Impact factor: 22.113

Review 9.  Gene therapy in in vivo isolated perfusion models.

Authors:  Boudewijn van Etten; Alexander M M Eggermont; Sandra T van Tiel; G Ambagtsheer; Johannes H W de Wilt; Timo L M ten Hagen
Journal:  Curr Gene Ther       Date:  2005-04       Impact factor: 4.391

10.  Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies.

Authors:  S K Libutti; D L Barlett; D L Fraker; H R Alexander
Journal:  J Am Coll Surg       Date:  2000-11       Impact factor: 6.113
View more
  3 in total

Review 1.  Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.

Authors:  Vedell Louis Jeune; Jakob A Joergensen; Roger J Hajjar; Thomas Weber
Journal:  Hum Gene Ther Methods       Date:  2013-04-03       Impact factor: 2.396

2.  Obstacles and future of gene therapy for hemophilia.

Authors:  Valder R Arruda; Ben J Samelson-Jones
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-18       Impact factor: 0.694

Review 3.  Gene therapy to treat cardiovascular disease.

Authors:  Julie A Wolfram; J Kevin Donahue
Journal:  J Am Heart Assoc       Date:  2013-08-20       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.